In 4 centers with beating-heart operation experience, there is an overall early benefit in off-pump surgery, especially in patients traditionally considered at high risk for coronary artery bypass grafting.
Background and Purpose
—Early postoperative stroke is a serious adverse event after coronary artery bypass grafting (CABG). This study sought to investigate risk factors, prevalence, and prognostic implications of postoperative stroke in patients undergoing CABG.
Methods
—We investigated the predictors of postoperative stroke (n=333, 2%) in 16 528 consecutive patients who underwent CABG between September 1989 and June 1999 in our institution. Predictors of postoperative stroke were identified by logistic regression analysis.
Results
—Among the preoperative and postoperative factors, significant correlates of stroke included (1) chronic renal insufficiency (
P
<0.001), (2) recent myocardial infarction (
P
=0.01), (3) previous cerebrovascular accident (
P
<0.001), (4) carotid artery disease (
P
<0.001), (5) hypertension (
P
<0.001), (6) diabetes (
P
=0.001), (7) age >75 years (
P
=0.008), (8) moderate/severe left ventricular dysfunction (
P
=0.01), (9) low cardiac output syndrome (
P
<0.001), and (10) atrial fibrillation (
P
<0.001). Postoperative stroke was associated with longer postoperative stay (11±4 versus 7±3 days for patients without stroke,
P
<0.001) and with higher in-hospital mortality (14% versus 2.7% for patients without stroke;
P
<0.001).
Conclusions
—Stroke after CABG is associated with high short-term morbidity and mortality. Increased stroke risk can be predicted by preoperative and postoperative clinical factors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.